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Robert H. Insall
Cyclic GMP and myosin II combine in a novel way to
protect Dictyostelium cells from changes in external
osmolarity. A newly discovered homologue of bacterial
histidine kinases is also required for resistance to
osmotic shock and may be a part of the same system.
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The second messenger cyclic GMP (cGMP) is a biological
enigma. Chemically, it is very similar to cyclic AMP, a
signalling molecule whose functions are well understood
and well conserved throughout eukaryotes. The role of
cGMP is much less clear, however, and varies remarkably
between cell types. A recent report [1] reveals a novel and
unexpected function for cGMP, in promoting resistance to
osmotic shock in Dictyostelium.
A message with many meanings
Signalling through cGMP is central to a broad range of
processes including vertebrate light detection, hormonal
control of smooth muscle tone, changes in the behaviour
of invertebrate sperm in response to eggs, and chemotaxis
and motility in Dictyostelium amoebae. Levels of cGMP are
modulated by a different pathway in each of these cases.
In mammalian photoreceptor cells, light causes a transient
dip in cGMP levels by activating a cGMP phosphodi-
esterase. Invertebrate sperm detect egg-derived peptides
using receptor guanylyl cyclases, which couple ligand
binding to intracellular cGMP synthesis through a single
transmembrane domain; similar receptors mediate the
action of a number of mammalian hormones, including
atrial natriuretic peptide. Smooth muscle contraction has
recently (and intriguingly) been demonstrated to respond
to reactive, gaseous messengers such as nitric oxide (NO)
and, possibly, carbon monoxide (CO). NO and CO stimu-
late cGMP production by binding to the haem group of a
soluble guanylyl cyclase. Finally, when Dictyostelium cells
are stimulated by chemoattractants, intracellular cGMP
increases briefly up to ten-fold as a result of stimulation of
a soluble cyclase — but this particular enzyme is stimu-
lated through G protein pathways, not by gases (NO has
recently been shown to cause ADP-ribosylation of
Dictyostelium proteins, but without affecting cGMP levels).
The role of cGMP in Dictyostelium movement
The best-understood function of cGMP in Dictyostelium is
in the control of myosin II, the conventional two-headed
myosin made up of two heavy and four light chains. The
peak in cGMP levels that follows a sudden stimulation by
chemoattractants lasts for less than a minute and correlates
with a cell rounding and loss of direction which has been
described as a ‘cringe’. Evidence that the cringe is directly
caused by cGMP comes from the streamer F mutant
(stmF), which shows a greatly extended cGMP peak,
apparently as a result of a mutation in the gene for cGMP
phosphodiesterase, and which also exhibits a comparably
extended cringe [2]. During the cringe, myosin II
becomes phosphorylated on both heavy and light chains.
The heavy chain phosphorylation is associated with desta-
bilization of existing filaments, and could therefore allow
myosin II to mobilize and relocalize, whereas the light
chain phosphorylation causes activation of the myosin
motor. Again, mutations which alter cGMP levels also
alter both types of myosin II phosphorylation. In stmF
mutants, the peak in phosphorylation is delayed, and in
KI-10, a mutant which cannot activate guanylyl cyclase,
chemoattractants do not alter myosin II phosphorylation
[3]. Thus, cGMP seems to have two effects: it causes the
redistribution of myosin II and also activates it. The
cringe probably reflects a non-physiological, undirected
squeeze in cells which are being equally stimulated all
over their surfaces — there is no evidence that it happens
during normal chemotaxis up a gradient.
Unfortunately, this picture, in which cGMP controls
chemotaxis through the action of myosin II, is too simplis-
tic. Deletion of the gene for the myosin II heavy chain
(mhcA) causes — amazingly — only a limited loss of motil-
ity; mhcA– cells grow at nearly normal rates, move at about
half the speed of wild-type cells, and perform chemotaxis
reasonably well considering their diminished speed [4]. (In
most species, a failure in cytokinesis would be fatal, but
Dictyostelium cells are able to compensate by ‘traction-medi-
ated cytofission’, in which multinucleate cells literally tear
themselves in two by causing different halves of the cell to
walk in different directions.) The phenotypes of mutants
with defects in guanylyl cyclase are different, however.
Cells of KI-10, the strain in which guanylyl cyclase is
decoupled from receptor activation, and KI-8, which
exhibits almost no guanylyl cyclase activity, are completely
unable to perform chemotaxis, despite apparently normal
motility [5]. Chemotaxis must therefore require cGMP for
more than just myosin II function. Also, it has recently
been found that stmF phosphodiesterase mutant cells
affect the motility of nearby wild-type cells [6], which
would not be expected if the cGMP-induced changes in
motility are cell-autonomous. This work suggests that, as
well as affecting myosin II, cGMP is also required for the
transmission of signals from cells to their neighbours.
cGMP and osmosis
The role of cGMP in resisting osmotic forces appears to be
far simpler. Kuwayama et al. [1] added 300 mM glucose to
growing cells and followed the consequences. Within ten
minutes of the onset of osmotic stress, wild-type cells
changed from a typical flattened morphology to a rounded,
rigid, non-motile form. The change in morphology corre-
lated with a redistribution of myosin II from the rear of
the cell and the pseudopodia to a uniform layer just below
the actin-rich cortex (Fig. 1). This result suggests that the
cell protects itself from the forces imposed by a hyper-
osmotic medium by increasing its cortical tension, per-
forming a slow squeeze which seems to considerably aid
survival. After a 30 minute treatment with 300 mM
glucose followed by redilution into buffer of low osmolar-
ity, nearly all the wild-type cells survived, whereas only
half the mhcA– cells were viable (although Kuwayama et al.
[1] did not distinguish between cells dying during osmotic
shock or following dilution). Furthermore, cells in which
the heavy chain phosphorylation sites had been removed
from myosin II survived as poorly as the mhcA– cells, even
though the unphosphorylatable myosin is sufficient for
nearly normal motility and cytokinesis. 
The phosphorylation-dependent redistribution of myosin
II is therefore a key part of the cell’s defence against
changes in the osmolarity of medium. It also correlates
with a previously unknown, long-term increase in cGMP
levels; peak concentrations are reached after 10 or more
minutes, compared with the 10 second peak seen in
response to chemoattractants. Kuwayama et al. [1] showed
that KI-8 cells cannot alter cGMP in response to osmotic
shock, and these cells also lose viability in hyperosmotic
medium at a similar rate to mhcA– cells. The similar kinet-
ics of cell death in the two strains suggest that in the
osmotic response, unlike the chemotactic response, the
sole effect of cGMP is on myosin II phosphorylation. In
addition, the only missing component in KI-8 cells is
cGMP: addition of the cell-permeant analogue 8-Br-cGMP
in combination with glucose-containing medium restored
survival to KI-8 cells, but did not assist mhcA– mutants.
Two-component systems and osmosis
Another well-known component of signalling pathways
also turns out to be crucial for survival in high osmolarities.
DokA, a recently identified gene [7], is required for sur-
vival after osmotic shock. DokA– cells were found to
survive the initial application of high-osmolarity medium,
but to lyse as soon as they were diluted back to normal,
low osmolarity conditions. This provides a plausible
mechanism for osmoprotection by cGMP and myosin II.
When cells move from high to low osmolarity, they suffer
an inrush of water which produces an expansive force.
Amoebae have no cell walls, so they must use their
cytoskeletons to resist the tendency to swell. The myosin
II squeeze seems to be Dictyostelium’s way of getting the
best of both worlds: in a comfortable environment nothing
obstructs the cell’s movement, but under osmotic stress an
actomyosin shell provides a de facto cell wall.
DokA encodes a homologue of bacterial histidine kinases
fused to a response regulator domain. The bacterial pro-
teins are known as ‘two-component systems’, because they
consist of a histidine kinase whose activity is modulated by
a sensor domain, along with a cognate response regulator.
Activation of the sensor causes autophosphorylation of the
histidine kinase, followed by transfer of the phosphoryl
group to an aspartyl residue in the response regulator. The
phosphorylation state of the response regulator controls
downstream processes, such as movement and gene
expression, in response to a wide range of environmental
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Figure 1
(a) In a moving wild-type cell, actin is found in the cortex and
pseudopodia, and myosin II is at the rear and in the pseudopodia.
(b) After osmotic shock, the cell shrinks to half its normal size; the
actin is in the cortex and the myosin II in a layer beneath the cortex. (c)
An unshocked cell, and (d) a cell shocked with 300 mM glucose for
10 min; actin is visualized in red and myosin II in green. The
photographs were kindly provided by Richard Tuxworth.
Actin
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conditions, such as nutrient concentration, nitrogen avail-
ability, redox potential, and osmolarity. Previously
thought to be specific to bacteria, two-component
systems have recently been discovered in eukaryotes
including Saccharomyces [8], Arabidopsis [9], and Dic-
tyostelium; the latter apparently uses a separate two-com-
ponent system, based around the dhkA histidine kinase
[10], to control spore formation. DokA resembles the yeast
SLN1 gene [8], which is also required for survival under
unfavourable osmotic conditions. Both encode hybrid
proteins in which both sensor and response regulator are
fused — in other words, a ‘one-component system’.
However, unlike SLN1 or EnvZ (a similar osmosensor in
Escherichia coli), dokA encodes nothing which resembles a
membrane-spanning domain. Whatever factor it senses is
therefore, presumably, intracellular.
The possible connections between the two newly discov-
ered osmoregulatory systems are fascinating, and details
will undoubtedly soon begin to emerge. The most intu-
itively likely pathway, in which dokA encodes the sensor
which induces cGMP production in response to osmotic
stress, was ruled out by Schuster and colleagues [7], who
found normal osmolarity-induced synthesis of cGMP in
dokA– mutants. The converse — that dokA encodes the
protein which couples the intracellular cGMP concentra-
tion to myosin II phosphorylation — would be unex-
pected. Two-component systems are usually the initial
sensors of environmental conditions, not found halfway
down the chain of command. This hypothesis is easily
testable, as it predicts that dokA– mutants should lose the
cGMP-mediated cringe and phosphorylation of myosin II
seen in wild-type cells in response to chemoattractants.
The effect on chemotaxis could be small, however: as dis-
cussed earlier, myosin II phosphorylation appears to be
only a part of cGMP’s contribution to the chemotaxis
response. The other possible alternative is that the
cGMP–myosin II and dokA pathways are independent, but
both are necessary for resistance to osmotic shock. If this
is the case, what is dokA doing to complement the osmotic
squeeze?
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